These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 38656456)
1. Exploring Pyroptosis-related Signature Genes and Potential Drugs in Ulcerative Colitis by Transcriptome Data and Animal Experimental Validation. Zhao Y; Ma Y; Pei J; Zhao X; Jiang Y; Liu Q Inflammation; 2024 Dec; 47(6):2057-2076. PubMed ID: 38656456 [TBL] [Abstract][Full Text] [Related]
2. Construction of a molecular inflammatory predictive model with histone modification-related genes and identification of CAMK2D as a potential response signature to infliximab in ulcerative colitis. Ye S; Lyu Y; Chen L; Wang Y; He Y; Li Q; Tian L; Liu F; Wang X; Ai F Front Immunol; 2023; 14():1282136. PubMed ID: 38274809 [TBL] [Abstract][Full Text] [Related]
3. Constructing a screening model to obtain the functional herbs for the treatment of active ulcerative colitis based on herb-compound-target network and immuno-infiltration analysis. Ou H; Ye X; Huang H; Cheng H Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):4693-4711. PubMed ID: 38117365 [TBL] [Abstract][Full Text] [Related]
4. Identification of ferroptosis-related genes in ulcerative colitis: a diagnostic model with machine learning. Qian R; Tang M; Ouyang Z; Cheng H; Xing S Ann Transl Med; 2023 Feb; 11(4):177. PubMed ID: 36923072 [TBL] [Abstract][Full Text] [Related]
5. Identification of Immune-Related Gene Signature and Prediction of CeRNA Network in Active Ulcerative Colitis. Xu M; Kong Y; Chen N; Peng W; Zi R; Jiang M; Zhu J; Wang Y; Yue J; Lv J; Zeng Y; Chin YE Front Immunol; 2022; 13():855645. PubMed ID: 35392084 [TBL] [Abstract][Full Text] [Related]
6. Identification of subclusters and prognostic genes based on GLS-associated molecular signature in ulcerative colitis. Xie Y; Li J; Tao Q; Wu Y; Liu Z; Chen Y; Zeng C Sci Rep; 2024 Jun; 14(1):13102. PubMed ID: 38849409 [TBL] [Abstract][Full Text] [Related]
7. Identification of key genes and biological processes contributing to colitis associated dysplasia in ulcerative colitis. Zhang D; Yan P; Han T; Cheng X; Li J PeerJ; 2021; 9():e11321. PubMed ID: 33987007 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of endoplasmic reticulum stress-associated genes signature of ulcerative colitis. Deng B; Liao F; Liu Y; He P; Wei S; Liu C; Dong W Front Immunol; 2023; 14():1158648. PubMed ID: 37287987 [TBL] [Abstract][Full Text] [Related]
9. Biomarkers prediction and immune landscape in ulcerative colitis: Findings based on bioinformatics and machine learning. Yang Y; Hua Y; Zheng H; Jia R; Ye Z; Su G; Gu Y; Zhan K; Tang K; Qi S; Wu H; Qin S; Huang S Comput Biol Med; 2024 Jan; 168():107778. PubMed ID: 38070204 [TBL] [Abstract][Full Text] [Related]
10. Identification of shared gene signatures and molecular mechanisms between chronic kidney disease and ulcerative colitis. Liang Z; Hu X; Lin R; Tang Z; Ye Z; Mao R; Chen W; Zhou Y Front Immunol; 2023; 14():1078310. PubMed ID: 36860851 [TBL] [Abstract][Full Text] [Related]
11. Identifying neutrophil-associated subtypes in ulcerative colitis and confirming neutrophils promote colitis-associated colorectal cancer. Zhang C; Zhang J; Zhang Y; Song Z; Bian J; Yi H; Ma Z Front Immunol; 2023; 14():1095098. PubMed ID: 36845139 [TBL] [Abstract][Full Text] [Related]
12. Pyroptosis-Related Signature Predicts the Progression of Ulcerative Colitis and Colitis-Associated Colorectal Cancer as well as the Anti-TNF Therapeutic Response. Ning Y; Lin K; Fang J; Chen X; Hu X; Liu L; Zhao Q; Wang H; Wang F J Immunol Res; 2023; 2023():7040113. PubMed ID: 36741232 [TBL] [Abstract][Full Text] [Related]
13. Evaluating the significance of ECSCR in the diagnosis of ulcerative colitis and drug efficacy assessment. Feng B; Zhang Y; Qiao L; Tang Q; Zhang Z; Zhang S; Qiu J; Zhou X; Huang C; Liang Y Front Immunol; 2024; 15():1426875. PubMed ID: 39170615 [TBL] [Abstract][Full Text] [Related]
14. Analysis and identification of ferroptosis-related genes in ulcerative colitis. Chen C; Lan B; Xie G; Liu Z Scand J Gastroenterol; 2023; 58(12):1422-1433. PubMed ID: 37530128 [TBL] [Abstract][Full Text] [Related]
15. Identification of Pharmacological Autophagy Regulators of Active Ulcerative Colitis. Qiu P; Liu L; Fang J; Zhang M; Wang H; Peng Y; Chen M; Liu J; Wang F; Zhao Q Front Pharmacol; 2021; 12():769718. PubMed ID: 34925026 [No Abstract] [Full Text] [Related]
16. Exploring the common diagnostic gene KCNJ15 and shared pathway of ankylosing spondylitis and ulcerative colitis through integrated bioinformatics. Zhou SZ; Shen L; Fu ZB; Li H; Pan YL; Yu RZ Front Physiol; 2023; 14():1146538. PubMed ID: 37215183 [No Abstract] [Full Text] [Related]
17. Elucidating the role of TWIST1 in ulcerative colitis: a comprehensive bioinformatics and machine learning approach. Ou W; Qi Z; Liu N; Zhang J; Mi X; Song Y; Fang Y; Cui B; Hou J; Yuan Z Front Genet; 2024; 15():1296570. PubMed ID: 38510272 [No Abstract] [Full Text] [Related]
18. Exploring the butyrate metabolism-related shared genes in metabolic associated steatohepatitis and ulcerative colitis. Deng B; Liu Y; Chen Y; He P; Ma J; Tan Z; Zhang J; Dong W Sci Rep; 2024 Jul; 14(1):15949. PubMed ID: 38987612 [TBL] [Abstract][Full Text] [Related]
19. PANoptosis and Autophagy-Related Molecular Signature and Immune Landscape in Ulcerative Colitis: Integrated Analysis and Experimental Validation. Lu J; Li F; Ye M J Inflamm Res; 2024; 17():3225-3245. PubMed ID: 38800594 [TBL] [Abstract][Full Text] [Related]
20. Precision therapy for ulcerative colitis: insights from mitochondrial dysfunction interacting with the immune microenvironment. Zhang YF; Fan MY; Bai QR; Zhao R; Song S; Wu L; Lu JH; Liu JW; Wang Q; Li Y; Chen X Front Immunol; 2024; 15():1396221. PubMed ID: 39026683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]